In CV disease, clopidogrel reduces nonfatal MI and MACE vs. aspirin but not stroke or mortality

Ann Intern Med. 2022 Dec;175(12):JC137. doi: 10.7326/J22-0094. Epub 2022 Dec 6.

Abstract

Tasoudis PT, Kyriakoulis IG, Sagris D, et al. Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis. Thromb Haemost. 2022;122:1879-87. 35577054.

Publication types

  • Comment

MeSH terms

  • Aspirin / adverse effects
  • Cardiovascular Diseases* / chemically induced
  • Clopidogrel
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects
  • Stroke* / chemically induced

Substances

  • Aspirin
  • Clopidogrel
  • Platelet Aggregation Inhibitors